NOVA Chemicals and Revolution Team Up to Meet Demand for Recycled Plastic
New Supply of PCR for Flexible Packaging Available January 2021
Calgary, Alberta, Canada , Dec. 10, 2020 (GLOBE NEWSWIRE) -- NOVA Chemicals Corporation (“NOVA Chemicals”) and Revolution today announced an agreement for NOVA Chemicals to sell recycled low / linear low-density polyethylene (r(L)LDPE) produced by Revolution. The agreement marks Revolution’s exclusive partnership with a resin manufacturer and builds NOVA Chemicals’ portfolio of post-consumer resin (PCR) offerings for its customers.
Revolution manufactures plastic films for a variety of consumer and industrial products and packaging, which they recapture after use to recycle and reuse in new products. This agreement will utilize a portion of this “closed-loop” plastic. NOVA Chemicals will begin to provide these resins in January 2021.
“Working with Revolution, a company that shares our passion for advancing the circular economy, we will further widen our product offerings for recycled plastics,” said Luis Sierra, president and CEO, NOVA Chemicals. “Together we will offer a portfolio of PCR that is available immediately to enable our customers and brand owners to meet their sustainability goals.”
Per the New Plastics Economy Global Commitments 2019 Progress Report, demand for PCR is expected to increase fivefold by 2025 (from a 2018 baseline) as brand owners work to reach ambitious goals for recycled content in packaging. NOVA Chemicals will be offering a number of r(L)LDPE grades from Revolution with different melt indexes and densities to help bridge the gap. The grades are ideal for use in flexible packaging applications such as heavy duty sack, shrink and stretch wrap, agricultural film, poly mailers and pouches, as well as a range of molded goods.
“We’re thrilled to collaborate with NOVA Chemicals to help more customers looking for high quality post-consumer recycled content,” said Sean Whiteley, CEO, Revolution. “Creating a circular economy for plastics is at the core our company’s mission. For more than 20 years, we’ve been putting high quality PCR back into new flexible packaging, and we are excited to expand the positive sustainability impact to more applications with NOVA Chemicals.”
In addition to recycled resins, NOVA Chemicals also offers technical support to help customers incorporate PCR into applications while meeting rigorous performance requirements. NOVA Chemicals’ dedicated PCR team has extensive PCR expertise coupled with technical facilities at the company’s Innovation Centres which are equipped with industry-leading production, conversion and test equipment.
“The relationship we’ve built with Revolution will have a significant impact on the market for recycled plastics,” said Greg DeKunder, vice president, polyethylene marketing, NOVA Chemicals. “Joining forces enables NOVA Chemicals to be a one-stop shop for our customers’ PCR needs, and to provide the peace of mind that comes with buying from NOVA Chemicals.”
To learn more about this agreement and NOVA Chemicals’ focus on the PCR market, please visit www.novachem.com/pcr.
About NOVA Chemicals
NOVA Chemicals develops and manufactures chemicals and plastic resins that make everyday life safer, healthier and easier. Our employees work to ensure health, safety, security and environmental stewardship through our commitment to sustainability and Responsible Care®. NOVA Chemicals, headquartered in Calgary, Alberta, Canada, is wholly-owned, ultimately by Mubadala Investment Company of the Emirate of Abu Dhabi, United Arab Emirates. www.novachem.com
Headquartered in Little Rock, Arkansas, Revolution Believes in Better Plastics that help preserve our environment for future generations. Spanning nearly every industry, the company's family of brands deliver sustainable, high-quality plastic products to both consumers and companies alike. Its brands include Delta Plastics, Revolution Bag, Revolution Ag, Rodeo Plastics, Polar Plastics, and Command. The focus in all areas is to create sustainable circular solutions and use as much post-consumer resin as possible in all products manufactured. For more information, visit www.revolutioncompany.com.
For further information, please contact:
NOVA Chemicals Media Relations
Trade PR Manager
NOVA Chemicals Investor Relations
Financial Reporting & Investor Relations Manager
Revolution Media Relations
Director of Marketing
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Saniona received approximately USD $2.9 million (SEK 24.2 million) upfront payment in connection with Cadent Therapeutics transaction25.1.2021 14:00:00 CET | Press release
PRESS RELEASE January 25, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced it received approximately USD $2.9 million (SEK 24.2 million) in an upfront payment resulting from the now completed acquisition of Cadent Therapeutics by a third party. Saniona holds an ownership stake of approximately 3% in Cadent Therapeutics resulting from Cadent’s previous acquisition of the Saniona spin-out Ataxion, which was created to leverage Saniona’s ion channel expertise for the treatment of movement disorders. Saniona previously announced the planned acquisition and its ownership stake in December 2020. “Saniona has developed a robust, proprietary drug discovery engine focused on ion channels, a rare scientifically validated drug class that remains significantly untapped,” said Jørgen Drejer, Chief Scientific Officer of Saniona. “It is gratifying to see our ion channel programs create value, and the funding that Saniona received from th
Saniona har erhållit upfrontbetalning om cirka 2,9 miljoner USD (24,2 miljoner SEK) i samband med förvärvet av Cadent Therapeutics25.1.2021 14:00:00 CET | Pressemelding
PRESSMEDDELANDE 25 januari 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, tillkännagav idag att Saniona tillförts cirka 2,9 miljoner USD (24,2 miljoner SEK) i upfrontbetalning, till följd av det nu genomförda förvärvet av Cadent Therapeutics av en tredje part. Saniona har en ägarandel om cirka 3 % i Cadent Therapeutics efter Cadents tidigare förvärv av Sanionas avknoppning Ataxion, som bildades för att utnyttja Sanionas expertis inom jonkanaler för behandling av motoriska störningar. Saniona har tidigare, i december 2020, meddelat om det planerade förvärvet samt bolagets ägarandel. ”Saniona har utvecklat en robust, proprietär plattform för upptäckter av nya läkemedel med fokus på jonkanaler – en av ett fåtal vetenskapligt validerade läkemedelsklasser som fortfarande är i huvudsak outnyttjade”, säger Jørgen Drejer, Chief Scientific Officer på Saniona. "Det är glädjande att se att våra jonkanalsprogram skapar värde och de
DFDS A/S: DFDS udvider logistikaktiviteter i Sverige med ny lagerbygning i Borås25.1.2021 13:51:10 CET | pressemeddelelse
Investor News DFDS har i dag indgået aftale om at lease en ny lagerbygning på 34.560 kvadratmeter i Borås, der er et attraktivt logistikknudepunkt for Skandinavien tæt på Gøteborg. Den nye lagerbygning udvider DFDS’ kontraktlogistikforretning, som i dag er koncentreret i Gøteborg. Den ekstra kapacitet gør det muligt at skabe vækst for eksisterende industrikunder samt tiltrække nye kunder. Lagerbygningen udvikles og opføres af udviklingsselskabet, CH Square, som DFDS leaser lagerbygningen af på en 10-årig aftale med mulighed for at forlænge aftalen efter leasingperioden. Byggeriet forventes at gå i gang i begyndelsen af februar 2021, og lagerbygningen forventes at åbne ved årets udgang. Der er ikke væsentlige investeringer knyttet til den nye lagerbygning. Den investerede kapital forventes at blive omkring DKK 80 mio. efter kapitalisering af leasingkontrakten i henhold til IFRS 16. Kontakt Torben Carlsen, CEO +45 33 42 32 01 Karina Deacon, CFO +45 33 42 33 42 Søren Brøndholt Nielsen, IR
DFDS A/S: DFDS expands logistics offering in Sweden with new warehouse in Borås25.1.2021 13:51:10 CET | Press release
Investor news DFDS has today entered into an agreement to lease a new 34,560 sqm warehouse in Borås, Sweden, that is an attractive Scandinavian logistics hub area close to Gothenburg. The new warehouse will expand DFDS’ contract logistics offering that today is focused in Gothenburg. The additional capacity will make it possible to grow with existing industrial customers and attract new customers. The warehouse will be built by property developer, CH Square, from whom DFDS will lease the warehouse for 10 years with an option to extend further after the lease period. Construction is expected to begin in early February 2021 and the warehouse is planned to open at the end of this year. There are no material investments related to the new warehouse. The invested capital of the warehouse is expected to be around DKK 80m following capitalisation of the lease contract according to IFRS 16. Contact Torben Carlsen, CEO +45 33 42 32 01 Karina Deacon, CFO +45 33 42 33 42 Søren Brøndholt Nielsen,
Sparebank 1 SMN: Innkalling til valgmøte for egenkapitalbeviseiere i SpareBank 1 SMN25.1.2021 11:05:00 CET | Pressemelding
Se vedlegg. Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 Vedlegg Innkalling 2021Påmeldingsskjema 2021
SpareBank 1 SMN: Notice of election meeting for the holders of Equity Capital Certificates (ECCs) in SpareBank 1 SMN.25.1.2021 11:05:00 CET | Press release
See enclosure. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments ECC Notice 2021ECC FORM OF PROXY 2021
Talenom Plc will publish its Financial Statements Bulletin for 2020 on 8 February 2021 at 13:30 EET25.1.2021 11:00:00 CET | Press release
Talenom Plc, Press release 25 January 2021 at 12:00 EET Talenom Plc will publish its Financial Statements Bulletin for 2020 on 8 February 2021 at 13:30 EET Talenom Plc will publish its Financial Statements Bulletin for 2020 on Monday 8 February 2021 at 13:30 EET. The company’s CEO Otto-Pekka Huhtala will present the highlights of the release for analysts, investors and media in Finnish, followed by CFO Antti Aho’s presentation in English as a live webcast on Monday 8 February 2021 at 14:00 EET. The webcast can be viewed online at https://talenom.videosync.fi/tilinpaatos-2020. Participants will have the opportunity to present questions during the briefing over the webcast platform. The presentation materials will be published before the start of the briefing on the company’s website at Talenom.fi/en/investors. TALENOM PLC Further information: Otto-Pekka Huhtala CEO, Talenom Plc +358 40 703 8554 firstname.lastname@example.org Talenom is an agile and progressive accounting firm established